Increased investment in antibiotics and overcoming barriers to development are crucial to combat rising antibiotic resistance. The PATH Act aims to rejuvenate antibiotic R&D by addressing challenges such as competition for funding, limited pipeline drugs, and difficulty in conducting trials due to a

0 views • 11 slides

BARDA is hosting the Just Breathe ARDS Therapeutics Pitch Event to find host-directed therapeutic candidates for an upcoming ARDS clinical trial. The presentation covers submission guidelines, event basics, submission deadlines, evaluation criteria, and more. Drug sponsors are invited to participate

0 views • 23 slides